400 related articles for article (PubMed ID: 7488313)
1. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
[TBL] [Abstract][Full Text] [Related]
2. Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats.
Torfgård KE; Ahlner J; Axelsson KL; Norlander B; Bertler A
Drug Metab Dispos; 1992; 20(4):553-8. PubMed ID: 1356734
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels of glyceryl trinitrate and dinitrates during application of three strengths of a new glyceryl trinitrate transdermal patch.
Santoro A; Rovati LC; Follet M; Setnikar I; Caplain H; Gualano V
Arzneimittelforschung; 2000 Sep; 50(9):786-94. PubMed ID: 11050694
[TBL] [Abstract][Full Text] [Related]
4. Bioavailability and pharmacokinetic profile of glyceryl trinitrate and of glyceryl dinitrates during application of a new glyceryl trinitrate transdermal patch.
Santoro A; Rovati LC; Setnikar I; Caplain H; Gualano V
Arzneimittelforschung; 2000 Sep; 50(9):779-85. PubMed ID: 11050693
[TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
Jensen KM; Dahl JB
Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its two dinitrate metabolites in conscious dogs.
Lee FW; Salmonson T; Metzler CH; Benet LZ
J Pharmacol Exp Ther; 1990 Dec; 255(3):1222-9. PubMed ID: 2124621
[TBL] [Abstract][Full Text] [Related]
7. Withdrawal of intravenous glyceryl trinitrate: absence of rebound phenomena with transition to oral isosorbide dinitrate.
Kelly EA; Ahmed RM; Horowitz JD
Clin Exp Pharmacol Physiol; 2005 Apr; 32(4):269-72. PubMed ID: 15810990
[TBL] [Abstract][Full Text] [Related]
8. Impaired nitroglycerin biotransformation in patients with chronic heart failure.
Petersson M; Rundqvist B; Bennett BM; Adams MA; Friberg P
Clin Physiol Funct Imaging; 2008 Jul; 28(4):229-34. PubMed ID: 18384624
[TBL] [Abstract][Full Text] [Related]
9. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Breedon TH; Bennett BM; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):608-14. PubMed ID: 3084761
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of nitroglycerin and its dinitrate metabolites in conscious dogs: intravenous infusion studies.
Lee FW; Salmonson T; Benet LZ
J Pharmacokinet Biopharm; 1993 Oct; 21(5):533-50. PubMed ID: 8145130
[TBL] [Abstract][Full Text] [Related]
11. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
12. Nitroglycerin dinitrate metabolites do not affect the pharmacokinetics and pharmacodynamics of nitroglycerin in the dog: a preliminary report.
Lee FW; Hu J; Metzler CH; Benet LZ
J Pharmacokinet Biopharm; 1993 Apr; 21(2):163-73. PubMed ID: 8229678
[TBL] [Abstract][Full Text] [Related]
13. Determination of glyceryl trinitrate and its two main metabolites in human plasma using a new sensitive gas chromatography method.
Ghandforoush-Sattari M; Zakeri-Milani P; Mashayekhi S; Valizadeh H
Arzneimittelforschung; 2011; 61(3):141-7. PubMed ID: 21528637
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Kobus SM; Kawamoto JH; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1988 Jan; 244(1):322-7. PubMed ID: 2826771
[TBL] [Abstract][Full Text] [Related]
15. [Comparative pharmacology of glycerol-1-nitrate and glyceryl trinitrate in various species].
Leitold M; Laufen H; Yeates RA
Arzneimittelforschung; 1986 May; 36(5):814-21. PubMed ID: 3089233
[TBL] [Abstract][Full Text] [Related]
16. The role of nitric oxide formation in organic nitrate-induced vasodilation and organic nitrate tolerance.
Marks GS; Nakatsu K; McLaughlin B; Kawamoto J; Slack C; Brien JF
Z Kardiol; 1989; 78 Suppl 2():18-21; discussion 64-7. PubMed ID: 2555978
[TBL] [Abstract][Full Text] [Related]
17. Bioequivalence evaluation of the metabolites 1,2 and 1,3-glyceryl dinitrate of two different glyceryl trinitrate patches after 12-h usage in healthy volunteers.
Hutt V; Sauter K; Pabst G; Bonn R; Fritschi E
Arzneimittelforschung; 1994 Dec; 44(12):1317-21. PubMed ID: 7848350
[TBL] [Abstract][Full Text] [Related]
18. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation.
Kawamoto JH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Cardiovasc Pharmacol; 1990 May; 15(5):714-9. PubMed ID: 1692930
[TBL] [Abstract][Full Text] [Related]
19. Endothelin receptor antagonism does not prevent the development of in vivo glyceryl trinitrate tolerance in the rat.
Ratz JD; Fraser AB; Rees-Milton KJ; Adams MA; Bennett BM
J Pharmacol Exp Ther; 2000 Nov; 295(2):578-85. PubMed ID: 11046091
[TBL] [Abstract][Full Text] [Related]
20. Variable glyceryl dinitrate formation following infusions of glyceryl trinitrate at different vascular sites in the rat.
Nakashima E; Lau DT; Benet LZ
Pharm Res; 1991 Jul; 8(7):877-82. PubMed ID: 1924138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
